These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5076821)

  • 1. Statistical analysis of survival experiments.
    Hoel DG; Walburg HE
    J Natl Cancer Inst; 1972 Aug; 49(2):361-72. PubMed ID: 5076821
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonparametric joint estimators for disease resistance and survival functions in survival/sacrifice experiments.
    Kodell RL; Shaw GW; Johnson AM
    Biometrics; 1982 Mar; 38(1):43-58. PubMed ID: 7082762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.
    Peto R; Pike MC
    Biometrics; 1973 Sep; 29(3):579-84. PubMed ID: 4793138
    [No Abstract]   [Full Text] [Related]  

  • 4. An illness-death model for the study of the carcinogenic process using survival/sacrifice data.
    Kodell RL; Nelson CJ
    Biometrics; 1980 Jun; 36(2):267-77. PubMed ID: 7407315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonparametric estimation of the survival function when cause of death is uncertain.
    Racine-Poon AH; Hoel DG
    Biometrics; 1984 Dec; 40(4):1151-8. PubMed ID: 6534414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The statistical analysis of cancer inhibition/promotion experiments.
    Kokoska SM; Hardin JM; Grubbs CJ; Hsu C
    Anticancer Res; 1993; 13(5A):1357-63. PubMed ID: 8239506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical analysis of disease onset and lifetime data from tumorigenicity experiments.
    Lagakos SW; Ryan LM
    Environ Health Perspect; 1985 Nov; 63():211-6. PubMed ID: 4076085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical analysis of animal cancer chemoprevention experiments.
    Freedman LS; Midthune DN; Brown CC; Steele V; Kelloff GJ
    Biometrics; 1993 Mar; 49(1):259-68. PubMed ID: 8513108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of rubomycins C and B on survival in mice with transplanted lymphosarcoma (strain LIO-1)].
    Toddolimo OK; Leleshkina GN
    Antibiotiki; 1969 Jun; 14(6):542-5. PubMed ID: 5820092
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistical methods and analysis used for biological tests.
    Irwin JO
    Spec Rep Ser Med Res Counc (G B); 1968; 306():110-251. PubMed ID: 5657282
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of cause-of-death assignment on time-to-tumor analyses in animal carcinogenesis studies.
    Kodell RL; Farmer JH; Gaylor DW; Cameron AM
    J Natl Cancer Inst; 1982 Sep; 69(3):659-64. PubMed ID: 7050501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The application of Weibull parameter model to survival analysis of glioma].
    Jia HY; Wang JZ; Zhao JJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):229-32. PubMed ID: 12816719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of comparative carcinogenesis experiments based on multiple times to tumor.
    Gail MH; Santner TJ; Brown CC
    Biometrics; 1980 Jun; 36(2):255-66. PubMed ID: 7407314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival time and mode of death in treated and untreated mice with Bergen A4 ascites carcinoma.
    Hartveit F
    Cancer Res; 1967 Jan; 27(1):95-7. PubMed ID: 6020369
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical protection against long-term effects of whole-body exposure of mice to ionizing radiation. III. The effects of fractionated exposure to C57BI mice.
    Maisin JR; Gerber GB; Lambiet-Collier M; Mattelin G
    Radiat Res; 1980 Jun; 82(3):487-97. PubMed ID: 7384416
    [No Abstract]   [Full Text] [Related]  

  • 16. "Tumor target organs and rate of survival in long-living transgenic mice and their parental wild-type counterparts exposed to the carcinogen dimethylbenz(alpha)anthracene", by Kossoy George, Herzl Ben-Hur, Ruth Miskin and Isthak Zusman. In vivo 20: 543-548, 2006.
    Miskin R
    In Vivo; 2006; 20(6B):911-2. PubMed ID: 17203789
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimation of distributions of time to appearance of tumor and time to death from tumor after appearance in mice fed 2-acetylaminofluorene.
    Kodell RL; Farmer JH; Greenman DL; Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):89-102. PubMed ID: 7365388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing laboratory evidence for neoplastic activity.
    Mantel N
    Biometrics; 1980 Sep; 36(3):381-99. PubMed ID: 7213907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induction of hormonally dependent tumors by small amounts of curium-244].
    Rudnitskaia EI; Moskalev IuI; Semenov AI
    Radiobiologiia; 1981; 21(2):186-92. PubMed ID: 7244147
    [No Abstract]   [Full Text] [Related]  

  • 20. An alternative approach to the analysis of animal carcinogenicity studies.
    Stallard N; Whitehead A
    Regul Toxicol Pharmacol; 1996 Jun; 23(3):244-8. PubMed ID: 8812967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.